Table 2.
PRS | CCSS Original Cohort (790 Hypertensive Survivors; 2,782 Hypertension-Free Survivors) |
CCSS Expansion Cohort (160 Hypertensive Survivors; 1,729 Hypertension-Free Survivors) |
SJLIFE (728 Hypertensive Survivors; 1,806 Hypertension-Free Survivors) |
Combined Sample (1,678 Hypertensive Survivors; 6,317 Hypertension-Free Survivors) |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
OR (95% CI) | p Value | C-Index | OR (95% CI) | p Value | C-Index | OR (95% CI) | p Value | C-Index | OR (95% CI) | p Value | C-Index | |
Per SD change | 1.31 (1.20–1.42) | <0.001 | 0.736 | 1.33 (1.12–1.58) | <0.001 | 0.747 | 1.39 (1.26–1.54) | <0.001 | 0.788 | 1.34 (1.26–1.43) | <0.001 | 0.785 |
1st decile | Ref. | |||||||||||
2th–5th deciles | 1.17 (0.85–1.62) | 0.329 | 0.736 | 1.83 (0.93–3.63) | 0.082 | 0.745 | 1.18 (0.81–1.73) | 0.385 | 0.787 | 1.24 (0.99–1.56) | 0.066 | 0.784 |
6th–8th deciles | 1.44 (1.04–2.00) | 0.030 | 1.89 (0.95–3.77) | 0.072 | 1.76 (1.20–2.58) | 0.004 | 1.61 (1.27–2.03) | <0.001 | ||||
9th decile | 1.89 (1.29–2.79) | 0.001 | 2.29 (1.03–5.10) | 0.042 | 2.32 (1.46–3.70) | <0.001 | 2.08 (1.58–2.75) | <0.001 | ||||
10th decile | 2.63 (1.80–3.83) | <0.001 | 3.03 (1.39–6.60) | 0.005 | 2.60 (1.66–4.06) | <0.001 | 2.66 (2.03–3.48) | <0.001 |
Covariates included age at childhood cancer diagnosis, age at last follow-up, sex, body mass index, smoking status (current or former vs. never), physical activity (vigorous intensity exercise in metabolic equivalents), cohort (CCSS original cohort, CCSS expansion cohort, and SJLIFE), alkylating agents, heavy metals, abdominal radiation, hypothalamic-pituitary axis radiation, total body radiation, and nephrectomy.